Mable
AcquiredFirst personalized migraine clinic using genetics and telehealth.
San Francisco, United States · Founded 2019 · $3.3M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2019
- Website
- trymable.com
- Total Funding
- $3.3M
- Last Round
- $3.2M SeedJul 2022
- Rounds
- 2
About
Mable is a personalized migraine clinic using DNA to find and provide the right medication alongside continuous expert care Using our approach, patients have an 80% higher treatment satisfaction rate, have one extra day per week to enjoy their life and get 55% pain reduction.
Summary
Mable is a Digital Health company based in San Francisco, United States, founded in 2019. It has raised $3.3M in total across 2 rounds, most recently a $3.2M Seed round in Jul 2022. Investors include Initialized Capital and Y Combinator Continuity Fund.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Telehealth platform providing personalized health and wellness treatments for men and women, cove...
Digital health insurance company and healthcare super-app offering personalized health insurance,...

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
European digital healthcare platform connecting patients with licensed doctors via video consulta...

Digital healthcare platform connecting patients, hospitals, and doctors in China for online consu...
Novel DNA sequencing architecture to scale the ultra low cost whole genome
